Interferon alpha 2b topical - Helix BioPharma
Alternative Names: AP-001; Interferon-alpha-2b - Helix BioPharmaLatest Information Update: 14 Jan 2021
At a glance
- Originator Helix BioPharma
- Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Cervical dysplasia; Genital warts
Most Recent Events
- 14 Jan 2021 BetterLife Pharma announces intention to file an IND with the US FDA by Q1 2022
- 14 Jan 2021 BetterLife Pharma plans a pre-IND meeting with the US FDA in Q3 2021
- 01 Sep 2020 Altum Pharmaceuticals has been acquired by BetterLife Pharma